Full Text
PDG9 Economic Impact of Cardiovascular Benefit of Once-Weekly Semaglutide in Type 2 Diabetes Patients with High Cardiovascular Risk in China

Abstract

Authors

R. Zhen C.O.L. Ung H. Hu

Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×